Chicago / IL. (adm) ADM Ventures, the corporate venture capital arm of Archer Daniels Midland Company (ADM), announced its investment in Seventure’s Health For Life Capital (HFLC) Fund II. HFLC, based in Paris, is a leading venture capital fund dedicated to health, nutrition, microbiota and digital health.
«We view Seventure as the premier investor in microbiome startups focused on human health and nutrition, and since 2018, ADM has worked closely with the Seventure team to identify opportunities with microbiome solutions that can ultimately help with dietary supplements and food and beverage applications to serve as functional or proactive solutions,» said Darren Streiler, managing director of ADM Ventures. «We believe Seventure can help meet the long-term demand we see as the result of the convergence of food and pharmaceuticals and consumers looking more towards bioactives and nutrition for wellness solutions.»
The microbiome consists of trillions of micro-organisms that reside on or inside the human body. ADM’s primary interest is the vast, complex bacterial ecosystem that lives within the digestive tract and constitutes the majority of every individual’s unique microbiome.
«With a better understanding of how the microbiome ecosystem works, we can develop functional ingredients for dietary supplements and food and beverage solutions targeted to help improve overall health,» Streiler said. «We are focused on looking at new, innovative solutions that can lead to a more balanced bacterial system in your digestive tract, otherwise known as a healthy gut, and can help lead to better health.»
ADM is committed to discovering and leveraging nutritional ingredients that can be used for preventative health, as well as for treating common ailments or even chronic diseases in both humans and animals. The company’s new probiotics production facility in Valencia, Spain – which will significantly increase its post- and prebiotic production capacity – is planned to be online in 2022.
ADM is an established market leader for microbiome solutions, with an award-winning portfolio of products and ingredients, including NutraIngredients’ 2020 ‘Probiotic Product of the Year’, ADM’s Bio-Kult Migréa®; 2020 Ingredient of the Year in the Weight Management category, ADM’s Bifidobacterium lactis BPL1; and the 2020 Editor’s Award winner for Functional Food Innovation, ADM’s Bacillus subtilis PXN®21®, a live microbial strain shown to reduce the aggregation of α-synuclein, paving the way for future research in Parkinson’s disease.
OTHER TOPICS FROM THIS SECTION FOR YOU:
- LG Chem and ADM: Joint Ventures in Illinois are canceled
- Wendy’s: Company plans to expand into Europe
- Delivery Hero: may face significant fine due to antitrust violations
- Emmi Group: intends to acquire Mademoiselle Desserts
- AB Foods: announces strong H1-2024 performance
- DSM-Firmenich: Queen Maxima inaugurates new dual head office
- RBI: Announces Investments to Drive Growth in China
- Europastry S.A.: puts its IPO process on hold
- McCormick: Reports Second Quarter Performance
- Reborn Coffee: Closes Master License Agreement for UAE
- General Mills: Reports Fiscal 2024 Fourth-Quarter Results
- SunOpta expands plant for processing plant-based beverages
- Britannia: Operating profit grew 10 percent in FY-2023
- Tate + Lyle and CP Kelco to merge to leading global player
- Ülker Bisküvi: announces Q1-2024 financial results
- Europastry: intends to go public on the Spanish stock exchange
- Europastry S.A.: publishes 2023 Annual Report
- Swisslog: announces new Americas region headquarters
- Reborn Coffee: Expanding Omni-Channel Strategy
- Mondelez International and Lotus Bakeries Join Forces